-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-03
Values as of: 2025-04-03
The investment seeks to provide investment returns that closely correspond to the price and yield performance of the Nasdaq Composite Index?. The fund normally invests at least 80% of assets in common stocks included in the index. It uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index that have a similar investment profile to the entire index.
Company Website : www.fidelity.com
Currency: USD
Country : USA
Inception Date: 21/10/2013
Primary Benchmark: MSCI USA IMI/Financials GR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.12%
Management Expense Ratio: 0.08 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
CVE | Cenovus Energy Inc | 7.52 % |
EMMA | Emmaus Life Sciences Inc | 5.65 % |
ABL | Abacus Life Inc. | 3.57 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
XLF | Financial Select Sector SPDR®.. | 0.13 % |
+3.31 (+7.54%) |
USD 50.94B |
VFH | Vanguard Financials Index Fund.. | 0.10 % |
+8.22 (+7.84%) |
USD 11.40B |
FXO | First Trust Financials AlphaDE.. | 0.63 % |
+3.81 (+8.30%) |
USD 2.15B |
BIZD | VanEck BDC Income ETF | 0.41 % |
+1.02 (+7.31%) |
USD 1.46B |
VPC | Virtus Private Credit ETF | 0.00 % |
+1.11 (+5.98%) |
USD 0.07B |
BDCZ | UBS AG London Branch ELKS 4 | 0.00 % |
+1.32 (+8.04%) |
USD 0.02B |
IYF | iShares U.S. Financials ETF | 0.42 % |
+7.48 (+7.54%) |
N/A |
IAI | iShares U.S. Broker-Dealers & .. | 0.42 % |
+11.54 (+9.46%) |
N/A |
IYG | iShares U.S. Financial Service.. | 0.42 % |
+5.63 (+8.17%) |
N/A |
IAK | iShares U.S. Insurance ETF | 0.43 % |
+7.20 (+5.86%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
JMBS | Janus Henderson Mortgage-.. | 0.00 % | 0.35 % |
N/A |
USD 5.00B |
JAGG | 0.00 % | 0.07 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -3.51% | 59% | D- | 47% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -3.51% | 59% | D- | 46% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 14.46% | 59% | D- | 85% | B | ||
Dividend Return | 0.89% | 24% | F | 18% | F | ||
Total Return | 15.34% | 59% | D- | 83% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 141.51% | 65% | D | 79% | B- | ||
Dividend Return | 16.53% | 35% | F | 38% | F | ||
Total Return | 158.04% | 53% | F | 76% | C+ | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 17.28% | 65% | D | 79% | B- | ||
Dividend Return | 19.21% | 65% | D | 79% | B- | ||
Total Return | 1.93% | 53% | F | 45% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 25.73% | 59% | D- | 40% | F | ||
Risk Adjusted Return | 74.67% | 53% | F | 83% | B | ||
Market Capitalization | 0.38B | 57% | F | 68% | D+ |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.